World Vaccine Europe 2021

Our Contribution

Viroclinics-DDL will shed light on the topic: “Accessible & Agile SARS-CoV-2 Clinical Trial Supply Chains” on Day 3 of the conference [Oct 21st, at 10:00]. We will discuss the following topics:

  • Pre-requisites of successful agility in clinical trials – ACCESSIBILITY in it’s broadest sense
  • The importance of end-to-end supply chain solutions
  • Post Pandemic agility – necessity of scalable outsourcing strategies
  • And more …..

Meet our clinical trial, logistics experts and scientists at Booth 35.


Marc van Pruijssen, Director Global Logistics, Viroclinics Xellerate

Marc van Pruijssen holds a Bsc. In international marketing, as well as management & organizational sciences. He performed an Msc, studying Transport & Logistics at TIAS-NIMBAS in Tilburg. Before joining Viroclinics-DDL in 2020, he has been responsible for a variety of developing supply chain functions and new business set up: supply chain planning, transport and distribution center operations, strategy development, program management and new product introductions. Next to that he is Board member and VP Marketing of the Council of Supply Chain Management Professionals (CSCMP) Benelux Round Table.

Contact Speaker


Davide Molho, DVM joins Viroclinics Biosciences as Chief Executive Officer

Viroclinics Biosciences B.V. (“Viroclinics”) today announced the appointment of life sciences industry veteran Davide Molho, DVM as the company’s new Chief Executive Officer. Dr. Molho succeeds Bob van Gemen, PhD who has served as the company’s CEO since 2011. This transition is part of a planned succession strategy. Dr. Molho’s appointment will take effect on 1 August 2020.